Impurity effects on the crystallization of avermectin B1a

Journal of Crystal Growth

Volumn 291, Issue 2, 2006, Pages 448-454

  Liu, Ji ^a   Chang, Zhidong ^a   Sun, Xinghua ^a   Shen, Shufeng ^a   Lei, Chao ^a   Liu, Huizhou ^a  

^a INSTITUTE OF PROCESS ENGINEERING   (China)

Author keywords

A1. Avermectin; A1. Crystal morphology; A1. Crystallization; A1. Impurities; A1. Impurity incorporation; A1. Nucleation

Indexed keywords

ADSORPTION; CHROMATOGRAPHIC ANALYSIS; CRYSTALLINE MATERIALS; IMPURITIES; MORPHOLOGY; NUCLEATION;

AVERMECTIN; CRYSTAL MORPHOLOGY; IMPURITY INCORPORATION;

POLYSACCHARIDES;

EID: 33744544952     PISSN: 00220248     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrysgro.2006.03.030     Document Type: Article

References (11)

1. Burg R.W. et al. Antimicrob. Agents Chemother. 15 (1979) 361
2. F.J. Matthews, Process for isolation of avermectin B1 components with improved purity and subsequent isolation of B2 components, United States Patent 5,077,398, 31 December, 1991.
3. Xie Z., Chang Z.D., Sun X.H., Hu X., and Wang M.M. W.J. Li. Chin. J. Antibiot. 30 (2005) 58
4. Tian Y.M., Yang H., and Li Y.F. Chin. J. Pharm. 33 (2002) 432
5. Al-Jibbouri S., and Strege C. J. Ulrich. J. Crystal Growth 236 (2002) 400
6. Rashad M.M., Mahmoud M.H.H., Ibrahim I.A., and Abdel-Aal E.A. J. Crystal Growth 267 (2004) 372
7. Rauls M., Bartosch K., Kind M., Kuch St., Lacmann R., and Mersmann A. J. Crystal Growth 213 (2000) 116
8. Li S.Z., Li X.Y., and Wang D.Z. J. Colloid Interf. Sci. 279 (2004) 100
9. Ottens M., Lebreton B., Zomerdijk M., Rijkers M.P.W.M., Bruinsma O.S.L., and van der Wielen L.A.M. Ind. Eng. Chem. Res. 43 (2004) 7932
10. Springer J.P., Arison B.H., Hirshfield J.M., and Hoogsteen K. J. Am. Chem. Soc. 103 (1981) 4221
11. Prasad K.V.R., Ristic R.I., Sheen D.B., and Sherwood J.N. Int. J. Pharm. 215 (2001) 29